申请人:Takeda Chemical Industries, Ltd.
公开号:US05496946A1
公开(公告)日:1996-03-05
There is provided an improved process for producing novel compounds represented by the general formula: ##STR1## wherein the ring A/ represents a pyrrole ring which may be hydrogenated; X represents an amino, hydroxyl or mercapto group; R.sup.1, R.sup.2 and R.sup.3 each, being the same as or different from the other, represents hydrogen or an alkyl, alkenyl or alkynyl group which may be substituted; R.sup.4 represents OR.sup.5 wherein R.sup.5 represents hydrogen or a hydrocarbon group which may be substituted or NHCH(COOR.sup.6)CH.sub.2 CH.sub.2 COOR.sup.7 wherein R.sup.6 and R.sup.7 each represents hydrogen or a hydrocarbon group which may be substituted; and n represents an integer of 1 to 4, or a salt thereof from compounds represented by the general formula: ##STR2## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and n are the same as defined above; Y.sup.1 and Y.sup.2 each represents oxygen or sulfur atom; R.sup.8 and R.sup.9 each, being the same as or different from the other, represents a hydrocarbon group which may be substituted, or salts thereof by an intramolecular ring closure reaction to form a pyrrolopyrimidine ring and, if necessary, reducing pyrrole ring thus formed to pyrroline ring. The compounds are useful as antitumor agents.
提供了一种改进的制备新化合物的方法,该化合物通式表示为:##STR1## 其中环A /表示可能氢化的吡咯环; X表示氨基,羟基或巯基; R.sup.1,R.sup.2和R.sup.3分别与另一个相同或不同,表示氢或可取代的烷基,烯基或炔基; R.sup.4表示OR.sup.5,其中R.sup.5表示氢或可取代的碳氢基或NHCH(COOR.sup.6)CH.sub.2 CH.sub.2 COOR.sup.7,其中R.sup.6和R.sup.7各自表示氢或可取代的碳氢基; n表示1到4的整数,或其盐,来自通式表示的化合物:##STR2## 其中X,R.sup.1,R.sup.2,R.sup.3,R.sup.4和n与上述定义相同; Y.sup.1和Y.sup.2各表示氧或硫原子; R.sup.8和R.sup.9各自与另一个相同或不同,表示可取代的碳氢基,或其盐,通过分子内环闭合反应形成吡咯嘧啶环,并如有必要,还原形成的吡咯环至吡咯烃环。这些化合物可用作抗肿瘤剂。